Peripheral Blood Mononuclear Cells, Thyroid Cancer Remission, Fresh
$960
In stock
SKU
Category: Research Products
Product Description
Thyroid Cancer Remission mononuclear cells (MNCs) are separated from peripheral blood by a density gradient centrifugation protocol. MNCs are screened for the expression CD45 and checked for viability using flow cytometry. This highly pure population of cells makes them ideal for further isolations of specific cell types within the mononuclear fraction.
Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.
Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.
| Species | Human |
|---|---|
| Disease State | Diseased |
| Cell and Tissue Source | Peripheral Blood |
| Product Type | Primary Cells |
| Cell Type | Mononuclear Cells |
| Donor Attributes | Thyroid Cancer Remission |
| Viability | ≥95% by Flow Cytometry |
| Format | Fresh |
| Contains | PBS with 5% FBS and 0.5% BSA |
| Anticoagulant | EDTA |
Customers Also Viewed:
